News About: Pharm. Industry
Shinpoong’s GMP plant gets Europe’s approval
Shinpoong Phamaceutical’s new GMP plant for production of antimalarial drugs is gaining international certification.
The company said it received a final EU-GMP certification from the European Medicines Agency (EMA...
Concerns growing over downward trend of drug pricing
With the government’s relentless price cuts of drugs, there is widespread consensus in local industry that Korean drug manufacturers will not afford to spend their money on the development of new drugs.
The health ...
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, market watchers said
Multinational pharmaceutical...
Increased coverage for advanced breast cancer patients
The government will increase health insurance benefits for treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and ...
9 drug makers caught bribing hospitals
The country's antitrust regulator said Sunday that nine pharmaceutical companies were found to have provided rebate-offerings to area hospitals, it said Sunday.
The Fair Trade Commission imposed a combined 3 billio...
KPMA opens consultative center for pharmaceutical companies
The Korea Pharmaceutical Manufacturers Association opened a special center on its building in Seoul, Monday to provide its member companies with tailored consulting services on regulatory affairs, license and other af...
Ilyang to conduct Phase 3 study on new leukemia drug
Ilyang Pharmaceutical Co. says it will carry out its Phase III clinical trial for a new leukemia medicine IY5511.
The study is to be conducted for 250 leukemia patients in the chronic and accelerated phases of the ...
Ilyang gearing up for new drug development
In order to secure seamless growth engines, Ilyang Pharmaceutical is gearing up for the development of new drugs.
In a general shareholders meeting Friday, President Kim Dong-yeon said that the company will create ...
Foreign pharmaceutical stock holdings valued at 1.71 trillion won
The combined value of pharmaceutical stocks held by foreign investors in Korea has topped 1.71 trillion won as of May 26.
Accordign to Yakup.com, an information provider, foreign investors were holding 1.71 trillio...
Police probing multinational drug manfacturers over rebate
The police has begun investigating into foreign-invested pharmaceutical firms’ ndue business practices such as rebate-offering.
The police's latest investigation concerning the industry raised suspicions that more ...
